Loading…
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020 This bill provides for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Medicare/Medicaid
Continue access to molecular and advanced genomic testing via telehealth; HR 8845, Multi-Cancer Early Detection Screening Coverage Act; HR 2617 Consolidated Appropriations Act of 2023
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Continue access to molecular and advanced genomic testing via telehealth; HR 8845, Multi-Cancer Early Detection Screening Coverage Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Continue access to molecular and advanced genomic testing via telehealth; HR 8845, Multi-Cancer Early Detection Screening Coverage Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
Continue access to molecular and advanced genomic testing via telehealth; HR 8845, Multi-Cancer Early Detection Screening Coverage Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
Continue access to molecular and advanced genomic testing via telehealth; HR 8845, Multi-Cancer Early Detection Screening Coverage Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
| Republican |
| NJ |
| Jodey C. Arrington | Republican | TX |
| Lisa Blunt Rochester | Democratic | DE |
| Neal P. Dunn | Republican | FL |
| Raul Ruiz | Democratic | CA |
| Richard Hudson | Republican | NC |
| Roger Marshall | Republican | KS |
| Ron Kind | Democratic | WI |
| Sheila Jackson Lee | Democratic | TX |
| Tim Ryan | Democratic | OH |
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
Client expense: $490,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
Client expense: $490,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Issues related to oncology and multi cancer early detection, including diagnostics and screening, S.5051- A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests; H.R.8845-Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues related to oncology and multi cancer early detection, including diagnostics and screening, S.5051- A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests; H.R.8845-Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues pertaining to cancer screening, including draft 21st Century Cures Act 2.0 legislation H.R. 8845 (Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020), all provisions
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2020 · fourth_quarter · Health Issues
H.R. 8845 and S. 5051 - bills to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
H.R. 8845 and S. 5051 - bills to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Medicare Part D & B Coverage and Reimbursement Legislative proposals to change Medicare Part D Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicaid drug pricing reporting H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ESRD PPS, Medicare coverage ANPRM International Pricing Index Model for Medicare Part B Drugs Proposed Rule: Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization * Medicaid and 340B issues & drug discount program *Importation and Most Favored Nations * H.R.8845, Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
Client expense: $680,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Coverage for telemedicine in Medicare Metastatic Breast Cancer Access to Care Act (HR 2178/S 1374) Multi Cancer Early Detection Screening Coverage Act (HR 8845) Proposed waivers under Sections 1115 and 1332 of the Social Security Act Proposed rule related to Securing Updated and Necessary Statutory Evaluations Timely Proposed rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency Proposed rules on Notice of Benefit and Payment Parameters Interim final rule on Most Favored Nation policy Radiation Oncology Alternative Payment Model
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues related to cancer diagnostic testing; Medicare coverage of cancer screening tests; H.R. 8845/S.5051 Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act H.R.8845/S.5051 - The Multi Cancer Early Detection Screening Coverage Act H.R. 913/S.4742 Clinical Treatment Act Medicare coverage policies for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Proposed waivers under Sections 1115 and 1332 of the Social Security Act Proposed rule related to Securing Updated and Necessary Statutory Evaluations Timely Proposed rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency Proposed rules on Notice of Benefit and Payment Parameters Interim Final Rule on Most Favored Nation Policy Coverage for telemedicine in Medicare Radiation Oncology Alternative Payment Model 2021 Medicare Physician Fee Schedule Proposed Rule 2021 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · fourth_quarter · Health Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; Issues related to H.R. 8845 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening; Issues related to H.R. 8845 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
Client expense: $490,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Health Issues
Issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening, H.R. 8845/S. 5051- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening, H.R. 8845/S. 5051 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Oncology and early multi-cancer detection, including diagnostics and screening. H.R. 8845, The Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2020 · fourth_quarter · Medicare/Medicaid
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening. H.R. 8845, The Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020 (H.R.8845).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES